C5,C6-disubstituted 1H-indole-2-carboxamides:: Synthesis and cytotoxic activity in the human non-small lung cancer cell line NSCLC-N16-L16

被引:5
|
作者
Tsotinis, A
Gerasimopoulou, M
Vlachou, M
Moreau, D
Roussakis, C
机构
[1] Univ Athens, Fac Pharm, Dept Pharmaceut Chem, Athens 15771, Greece
[2] Fac Pharm, Lab Pharmacol Marine, ISOMER, Nantes, France
关键词
disubstituted; 1H-indole-2-carboxamides; synthesis; cytotoxicity;
D O I
10.2174/157018006775240980
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A facile synthesis of the disubstituted 1H-indole-2-carboxamides (6a-h) is described. Readily available 4-benzyloxy-3-methoxybenzaldehyde is converted to the parent acid (12) by nucleophilic attack of the azido-ester (9) and cyclization of the propenoic methyl ester (10). The target compounds (6a-d) were obtained by amidation of (12) with the appropriate primary amine. The new 6-hydroxy analogs (6e-h) were prepared by benzyl deprotection of (6a-d). The cytotoxicity of the new molecules was evaluated in the human non-small lung cancer cell line NSCLC-N16-L16 in vitro. One compound (6d) showed satisfactory activity (IC50 = 13.9 mu M) worthy of further study. It is noteworthy that few agents are clinically effective against human non-small lung cancer, and thus there is a need for novel agents for use in this disease.
引用
收藏
页码:14 / 16
页数:3
相关论文
共 25 条
  • [21] First-line (1L) nivolumab (N) plus ipilimumab (I) with 2 cycles of platinum-based chemotherapy (C) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC): Results from an interim analysis of the German non-interventional study (NIS) FINN
    Kuon, J. B.
    Von der Heyde, E.
    Sadjadian, P.
    Bischoff, M.
    Hassler, A.
    Althoff, A.
    Wilop, S.
    Behringer, D. M.
    Blau, W.
    Huebner, G.
    Flieger, D.
    Ziske, C.
    Groschek, M.
    Laack, H-E.
    Mueller-Huesmann, H.
    Schumann, C.
    Waldenberger, D.
    Guetz, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S852 - S852
  • [22] Roles of PI3K/Akt and c-Jun Signaling Pathways in Human Papillomavirus Type 16 Oncoprotein-Induced HIF-1α, VEGF, and IL-8 Expression and In Vitro Angiogenesis in Non-Small Cell Lung Cancer Cells
    Zhang, Erying
    Feng, Xiaowei
    Liu, Fei
    Zhang, Peihua
    Liang, Jie
    Tang, Xudong
    PLOS ONE, 2014, 9 (07):
  • [23] Proliferation arrest in G1 phase of a non-small cell lung cancer cell line (NSCLC-N6) treated by an original compound methyl-4-methoxy-3-(3-methyl-2-butanoyl) benzoate (VT1) independently of the p53/p21 cascade
    Jacquot, C
    Moreau, D
    Tomasoni, C
    Juge, M
    Coiffard, L
    Roussis, V
    Roussakis, C
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 23 (02) : 495 - 501
  • [24] Roles of PI3K/Akt and c-Jun Signaling Pathways in Human Papillomavirus Type 16 Oncoprotein-Induced HIF-1α, VEGF, and IL-8 Expression and In Vitro Angiogenesis in Non-Small Cell Lung Cancer Cells (vol 19, e0314378, 2024)
    Zhang, Erying
    Feng, Xiaowei
    Liu, Fei
    Zhang, Peihua
    Liang, Jie
    Tang, Xudong
    PLOS ONE, 2024, 19 (11):
  • [25] Phase III study of pembrolizumab plus MK-1084 vs pembrolizumab plus placebo as first-line treatment for metastatic non-small cell lung cancer (NSCLC) with a KRAS G12C mutation and PD-L1 tumour proportion score (TPS) ≥50%: MK-1084-004
    Cobb, P. W.
    Hochmair, M.
    Schuler, M. H. H.
    Riely, G. J.
    Rojas, C. I.
    Kim, S. J.
    Chen, X.
    Lara-Guerra, H.
    Felip, E.
    ANNALS OF ONCOLOGY, 2024, 35 : S871 - S872